Julian R Garneau (0000-0003-4579-8776)

Personal information

Biography

Post-doctoral researcher studying bacterial and bacteriophage genomics at the University of Lausanne, Switzerland. I aim to develop experimental and bioinformatic procedure to improve microbiota-targeted interventions and also to accelerate research regarding bacteriophages and microbiome in general. I am also interested in the role of bacteriophages on bacterial host virulence and biology in general. Dynamics and interplay of phages with bacterial populations is a topic of great interest to me.

Activities

Collapse all

University of Lausanne: Lausanne, CH

2022-06 to present | Post-doctoral researcher (Department of Fundamental Microbiology)

Employment

Julian R Garneau

https://orcid.org/0000-0003-4579-8776

Personal information

Emails & domains

Verified email addresses

Verified email domains

Websites & social links

Other IDs

Keywords

Countries

Biography

Activities

Employment (3)

University of Lausanne: Lausanne, CH

Institut Pasteur: Paris, FR

Université de Sherbrooke: Sherbrooke, QC, CA

Education and qualifications (4)

Université de Sherbrooke: Sherbrooke, QC, CA

Université de Sherbrooke: Sherbrooke, QC, CA

Bishop's University: Sherbrooke, QC, CA

Université Laval: Quebec, QC, CA

Works (21)

Exposure of gut bacterial isolates to the anthelminthic drugs, ivermectin and moxidectin, leads to antibiotic-like phenotypes of growth inhibition and adaptation

Novel phages of Pseudomonas syringae unveil numerous potential auxiliary metabolic genes

A phylogenetic host range index reveals contrasted relationships between phage virulence and specialisation

Novel phages ofPseudomonas syringaeunveil numerous potential auxiliary metabolic genes

The Response of the Honey Bee Gut Microbiota to Nosema ceranae Is Modulated by the Probiotic Pediococcus acidilactici and the Neonicotinoid Thiamethoxam

Molecular and evolutionary basis of O-antigenic polysaccharide-driven phage sensitivity in environmental pseudomonads

Molecular and evolutionary basis of O-antigenic polysaccharide driven phage sensitivity in environmental pseudomonads

Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027)<i>Clostridioides difficile</i>

The <i>Clostridioides difficile</i> S-Layer Protein A (SlpA) serves as a general phage receptor

Chromosome folding and prophage activation reveal gut-specific genome dynamics of bacteria in the OMM12 consortium

High-throughput identification of viral termini and packaging mechanisms in virome datasets using PhageTermVirome

Type I toxin-antitoxin systems contribute to the maintenance of mobile genetic elements in Clostridioides difficile

Multilocus Variable-Number Tandem-Repeat Analysis of Clostridioides difficile Clusters in Ribotype 027 Isolates and Lack of Association with Clinical Outcomes

High Prevalence and Genetic Diversity of Large phiCD211 (phiCDIF1296T)-Like Prophages in Clostridioides difficile

PhageTerm: a tool for fast and accurate determination of phage termini and packaging mechanism using next-generation sequencing data

Derivation and Validation of a Clinical Prediction Rule for Complications of Clostridium difficile Infection Using a Multicenter Prospective Cohort

External validation of clinical scores to predict complications of Clostridium difficile infection

External validation of predictive scores for mortality following Clostridium difficile infection

Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort.

Characterization of Temperate Phages Infecting Clostridium difficile Isolates of Human and Animal Origins

Prevention of Clostridium difficilespore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam